SCIENTIFIC HUB

Follow the evidence.

SCIENTIFIC LITERATURE · MED

USP10 in Neurological Disorders: Mechanistic Insights and Emerging Therapeutic Strategies.

Ann N Y Acad Sci · 2025-11-24

DOI: 10.1111/nyas.70144PMID: 41284210

Open accessResearch Support, Non-U.S. Gov't; review-article; Review; Journal ArticleOriginal source ↗

Research overview

The text below is the source article’s original abstract under a verified reuse license. cc by

Various cellular processes, such as DNA repair and signal transduction, are regulated through ubiquitination and deubiquitination. Dysregulation of ubiquitination cascade enzymes and deubiquitinating enzymes leads to various diseases. Among them, deubiquitinating enzymes have been shown to be closely associated with cancer, cardiovascular disease, and metabolic diseases. Recent studies have found that deubiquitinating enzymes play an important role in controlling neuronal fate, synaptic development, and maintaining normal nervous system function. USP10, a member of the deubiquitinating enzyme family, regulates the progression of various diseases by acting on different substrates and modulating their functions. USP10 has been shown to regulate neurological diseases by mediating pathways such as immune response, oxidative stress, and apoptosis. This review provides a comprehensive overview of the molecular structure of USP10, identifies its substrate-binding sites, and summarizes its biological functions, particularly in relation to neurological diseases, including Alzheimer's disease, Parkinson's disease, glioblastoma, and ischemic stroke. USP10 promotes pathological progression in Alzheimer's disease and glioblastoma on the one hand, and exerts protective effects in Parkinson's disease and ischemic stroke on the other. Additionally, we summarize recent progress in the development and application of USP10 modulators and potential therapeutic strategies targeting USP10 in neurological disorders.

Scientific assessment

01

Research question

Assess the question within the original study’s scope.

02

Methods & sample

Check the source article for study design and sample details.

03

Key findings

An editorially approved findings summary is not yet published for this record.

04

Limitations

Generalizability, bias and clinical meaning require separate assessment.

Methods, samples and clinical conclusions are not inferred from bibliographic metadata.